STAT3 and fibrosarcoma: Finally, with recent evidence demonstrating that Pyr and MTX induce their anti-cancer activity (at least in part) by halting STAT3 transcriptional activity, these compounds were assessed in the STAT3-dependent luciferase reporter assay using U3A (male) fibrosarcoma cells, as performed previously [4].